85% reduction in daily cases after May 7, only 60 thousand new cases

The lowest daily case in 75 days, 2762 deaths in 24 hours

Active cases fell further to 9.13 lakh, total death toll 3.77 lakh, total cases crossed 2.95 crore

Below five thousand active cases in 20 states and union territories

New Delhi: At least 60,471 new cases of corona virus have been reported in India in the last 75 days. At the same time, the total number of cases of Corona has crossed 2,95,70,881.

The daily positivity rate has come down to 3.45 per cent as the number of daily cases has come down. Corona, on the other hand, has killed 2,726 people in 24 hours. As a result, the total death toll has reached 3.77 lakh.

Active cases are now going below 10 lakh. At present, the number of active cases in the country has reached 9.13 lakh, which is 3.09 per cent of the total cases. While the national recovery rate has risen to 95.64 percent.

On Monday, 17.51 ​​lakh corona tests were conducted and the total number of tests has crossed 38.13 crore. Corona's highest number of cases came on May 7, after which the number of cases began to decline. Corona's daily cases have dropped by 85 percent since May 7, according to the government.

According to the data, the number of active cases in 20 Union Territories and states is less than 5,000. In the second wave of Corona, the virus has further engulfed the youth.

In the second wave, 11.62 per cent of all new corona cases were under the age of 20. While in the first wave this percentage was 11.31 percent. Currently, the States and Union Territories have 1.05 crore doses of Corona vaccine available. While other doses are being delivered. So far, a total of 26.69 crore doses have been provided to the states.

The vaccine costs Rs. Giving in 150 is not affordable in the long run: Bharat Biotech

"The central government is buying a dose of the vaccine from us for Rs 150, which is a very small amount," said Bharat Biotech, a company that manufactures corona vaccine called Covexin. Considering the cost of making a vaccine, if the vaccine is bought at such a high price, it will not last long. The company says it needs to meet higher vaccine prices in the private market as part of the cost. At present, India sells a single dose of the biotech covacin vaccine to the central government for Rs 150, to the states for Rs 400 and to private hospitals for Rs 1,200.